Published in

Royal Society of Chemistry, MedChemComm, 3(3), p. 312-321, 2012

DOI: 10.1039/c2md00238h

Links

Tools

Export citation

Search in Google Scholar

A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds

Journal article published in 2012 by Hongming Chen, Ola Engkvist, Niklas Blomberg ORCID, Jin Li
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Natural Products (NPs) and their subset Human Metabolites (HMs) are synthesized in living organisms and, due to their biogenic nature, can be used as starting points for drug discovery projects as well as a source of inspiration for designing new chemical libraries. It is therefore of interest to characterize NPs and HMs in relation to other types of molecules relevant for drug discovery. In this study, a comparative analysis of the molecular topologies was carried out for NPs, HMs, drugs from different time periods, clinical candidates and general bioactive compounds. It is shown that the NP and HM sets have the highest percentage of compounds with only one ring system. NPs have also the highest Ring System Complexity (RSC) of the compared datasets, while general bioactive compounds have the largest number of ring systems. The difference in molecular topology between the datasets is independent of the molecular size and lipophilicity. Further analysis of topological descriptors shows that NPs and HMs have a larger proportion of side chain atoms in relation to their size and have a higher proportion of aliphatic carbons (indicating a more three-dimensional shape) than compounds from the other sets.